✦ LIBER ✦

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

✍ Scribed by Rossi, D.; Bruscaggin, A.; Spina, V.; Rasi, S.; Khiabanian, H.; Messina, M.; Fangazio, M.; Vaisitti, T.; Monti, S.; Chiaretti, S.; Guarini, A.; Del Giudice, I.; Cerri, M.; Cresta, S.; Deambrogi, C.; Gargiulo, E.; Gattei, V.; Forconi, F.; Bertoni, F.; Deaglio, S.; Rabadan, R.; Pasqualucci, L.; Foa, R.; Dalla-Favera, R.; Gaidano, G.

Book ID: 118269170
Publisher: American Society of Hematology
Year: 2011
Tongue: English
Weight: 766 KB
Volume: 118
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2011-08-373159

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exome sequencing identifies recurrent mu

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

✍ Quesada, Víctor; Conde, Laura; Villamor, Neus; Ordóñez, Gonzalo R; Jares, Pedro; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 936 KB

Different impact of NOTCH1 and SF3B1 mut

Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome

✍ Davide Rossi; Silvia Rasi; Valeria Spina; Marco Fangazio; Sara Monti; Mariangela 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Rituximab Plus Fludarabine and Cyclophos

Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia

✍ Robak, T.; Dmoszynska, A.; Solal-Celigny, P.; Warzocha, K.; Loscertales, J.; Cat 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 282 KB

Prolonged progression-free survival in p

Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab

✍ Michaela Gruber; Karin Fleiss; Edit Porpaczy; Cathrin Skrabs; Alexander W. Hausw 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 144 KB

The Addition of Rituximab to Fludarabine

The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia

✍ Amit Mahipal; Mark Weiss 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 80 KB

Amifostine does not reduce the toxicity

Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia

✍ Francis J. Giles; Gary Guangping Shi; Jorge E. Cortes; Deborah Thomas; Anna R. K 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 189 KB